
ALGS
Healthcare · Biotechnology · $13.1M market cap
$2.10+0.12 (+6.1%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -10.4% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 6, 2026 | Before the open | -2.44 | -2.09 | +14.3% |
| Aug 6, 2026 | Before the open | -1.41 | -0.14 | +90.1% |
| May 8, 2026 | Time not confirmed | -2.25 | -2.21 | +1.6% |
| Mar 5, 2026 | Before the open | -2.49 | -1.91 | +23.3% |
| Nov 6, 2025 | Before the open | -2.01 | -3.04 | -51.2% |
| Aug 6, 2025 | After the close | -2.53 | -1.53 | +39.5% |
| May 6, 2025 | Before the open | -3.15 | 5.12 | +262.5% |
| Mar 10, 2025 | Before the open | -3.67 | -13.10 | -256.9% |
| Nov 6, 2024 | After the close | -1.32 | -3.07 | -132.6% |
| Aug 6, 2024 | After the close | -4.00 | 0.75 | +118.8% |
| May 7, 2024 | After the close | -4.75 | -5.50 | -15.8% |
| Mar 12, 2024 | After the close | -0.27 | -0.22 | +18.5% |
| Nov 2, 2023 | After the close | -11.87 |
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a…
| -10.25 |
| +13.6% |
| Aug 3, 2023 | After the close | -12.37 | -10.75 | +13.1% |
| May 4, 2023 | After the close | -12.12 | -13.25 | -9.3% |
| Mar 9, 2023 | After the close | -0.47 | -0.51 | -8.5% |
| Nov 2, 2022 | After the close | -14.52 | -11.00 | +24.2% |
| Aug 4, 2022 | After the close | -16.70 | -11.75 | +29.6% |
| May 4, 2022 | After the close | -18.08 | -21.00 | -16.2% |
| Mar 10, 2022 | After the close | -0.83 | -0.89 | -7.2% |
| Nov 4, 2021 | After the close | -20.59 | -19.50 | +5.3% |
| Aug 5, 2021 | After the close | -20.29 | -19.75 | +2.7% |
| May 10, 2021 | After the close | -23.51 | -18.50 | +21.3% |
| Mar 23, 2021 | After the close | -0.82 | -1.09 | -32.9% |
| Nov 25, 2020 | After the close | -24.72 | -13.98 | +43.4% |
| Sep 25, 2020 | Time not confirmed | — | -1.42 | — |